Aprea Therapeutics
APRE
APRE
18 hedge funds and large institutions have $3.77M invested in Aprea Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
18
Holding in Top 10
–
Calls
$615K
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$1.24M | |
| 3 | +$415K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$378K |
| 5 |
Morgan Stanley
New York
|
+$3.37K |
Top Sellers
| 1 | -$59K | |
| 2 | -$53K | |
| 3 | -$48K | |
| 4 |
Jane Street
New York
|
-$16.9K |
| 5 |
State Street
Boston,
Massachusetts
|
-$13.1K |